FindTrial
Sign In

Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review

Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review - Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000060930
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with limited life expectancy and frailty, irrespective of specific diseases.

Interventions

None listed

Sponsors

Tokyo University of Pharmacy and Life Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria were studies involving adult hospitalised patients with frailty. Only original research articles were included. No restriction was placed on the year of publication, and studies published in Japanese or English were eligible. Eligible studies were required to report clinical outcomes such as patients' quality of life (QOL), changes in the number of prescribed medications, discontinuation rates of potentially unnecessary medications, and the incidence of adverse events.

Exclusion criteria

Exclusion criteria: The exclusion criteria were review articles and studies that did not involve adult patients.

Design outcomes

Primary

MeasureTime frame
QOL—

Countries

Japan

Contacts

Public ContactTakenori Ichimura

Tokyo University of Pharmacy and Life Sciences Center for Experimental Pharmacy Practice, School of Pharmacy

ichimura@toyaku.ac.jp042-676-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026